Does previous percutaneous coronary intervention increase the risk of graft failure in subsequent coronary surgery?  by Nezic, Dusko et al.
Letters to the Editorcomplications and even of saving lives
can certainly be estimated.1 Indeed,
the very cornerstone of the health eco-
nomic discipline is to do exactly such
estimations across the most common
diseases to determine how limited
health care resources can be used most
effectively to benefit the most patients.
Knowing the economic consequences
of medical complications is a highly es-
sential step in our efforts to identify
cost-effective clinical interventions to
address them. In health care systems
with limited resources, policy makers,
health insurers, hospital administrators,
and practicing physicians need to con-
sider carefully the cost-effectiveness
of medical interventions, both in the
daily practice of medicine and as part
of long-term evaluation and planning
of quality improvement initiatives.
As we describe in our article, medi-
cal interventions can either be cost
saving (if the hospital’s cost savings
are greater than the cost of the inter-
vention), cost-effective (when the
incremental cost of a clinical interven-
tion is reasonable with regard to the
clinical benefits obtained), or cost en-
hancing (if the clinical intervention in-
duces higher hospital costs without
any clinical benefit). In the context of
excessive hemorrhage in cardiac sur-
gery, knowledge of the medical and
economic consequences of this com-
plication is the very first step in the
identification of safe, effective, and
cost-effective clinical interventions to
address this complication. Addition-
ally, awareness of the costs of exces-
sive hemorrhage may compel health
care professionals to apply preventive
and therapeutic measures as early as
possible. In our research we used sim-
ple and objective criteria for excessive
postoperative hemorrhage to allow
early identification of patients at risk
for severe morbidity or even a fatal
outcome. Early identification of bleed-
ing facilitates early treatment and
thereby improves outcome. This is
the very basis for improvement in
clinical care and applied quality im-
provement.1668 The Journal of Thoracic andOf course, health care providers
must primarily keep the individual pa-
tient’s health in mind. In addition,
however, we need to be aware of the
costs of complications to provide the
highest standard of care for all pa-
tients. This may be even more impor-
tant in the future, when rationing of
health care resources is likely to
become an even more dominant part
of our health care services.
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IN SUBSEQUENT CORONARY
SURGERY?
To the Editor:
We recently pointed out1 that there
is no evidence to support significantly
better angiographic patency with ra-
dial artery conduit than with saphe-
nous vein graft in coronary arteryCardiovascular Surgery c June 2010bypass grafting in controlled, random-
ized trials reported to date. We do not,
however, support inclusion of data ex-
tracted from the article by Gaudino
and associates2 in the recently pub-
lished meta-analysis by Benedetto
and colleagues3 of controlled, random-
ized trials comparing radial artery con-
duits and saphenous vein grafts with
respect to angiographic patency.
The article by Gaudino and associ-
ates2 reported 2 controlled, random-
ized trials including patients with
previous percutaneous stent implanta-
tion (in any coronary vessel) with pre-
operative angiographic confirmation
of a failed (I trial) or patent (II trial) in-
tracoronary stent. In that report,2 they
focused on the results of arterial versus
venous grafts directed to the first ob-
tuse marginal artery. There were, how-
ever, no data on failed stent location.
In a subsequent analysis4 of that initial
report, Gaudino and coworkers4 fo-
cused on the complementary venous
grafts to nonobtuse target coronary
vessels (right coronary artery and
circumflex artery other than the first
obtuse marginal artery). They con-
cluded that patients with development
of in-stent restenosis face a higher risk
of early venous graft failure (46 oc-
cluded of 84, patency rate 45.2% at
5 years after surgery). Even in that ar-
ticle, however, there were no precise
data about the number of failed venous
grafts that were distributed to targeted
coronary arteries with in-stent resteno-
sis. We were able to find out only that
25 of the failed stents were located on
a circumflex artery other than the first
obtuse marginal artery, 31 were lo-
cated on the right coronary artery,
and 7 were located on the left anterior
descending coronary artery. Although
43 venous graft–targeted vessels
were circumflex artery other than the
first obtuse marginal artery and 41
were right coronary artery, we must
face the possibility that the vast major-
ity of venous grafts were placed on
previously stented coronary arteries.
It has been argued by Gaudino and
associates2,4 that in-stent restenosis is
Letters to the Editorseen in a subgroup of patients with ag-
gressive coronary atherosclerosis.
Conversely, the pathophysiologic re-
sponse5 to the presence of an intravas-
cular foreign body (stent) may also
adversely affect the fate of the conduits
used to graft stented coronary arteries.
Stenting can cause prolonged endothe-
lial dysfunction, as well as an acute
and chronic inflammatory reaction,
even during the late period, with in-
volvement of the distal coronary artery
and surrounding myocardium.5 This
may adversely affect anastomosis sites
in patients who subsequently undergo
coronary artery bypass grafting.
A vexed question is whether the
poor fate of venous conduits used to
bypass coronary arteries with in-stent
restenosis is due to aggressive athero-
sclerosis or to an inflammatory reac-
tion involving downstream coronary
artery beds. Although we do not
know the distribution of occluded con-
duits with respect to stent locations,
we cannot definitively point out the
influences on graft patency. We there-
fore do not support inclusion of these
data in meta-analyses.
Dusko Nezic, MD, PhD, FETCS
Aleksandar Knezevic, MD, BcS
Petar Vukovic, MD, BcS
‘‘Dedinje’’ Cardiovascular Institute
Belgrade, Serbia
References
1. Nezic D, Knezevic A, Cirkovic M. Are we allowed to
declare radial artery graft with a ‘string sign’ for a pat-
ent conduit?EurJCardiothoracSurg. 2009;36:605-6.
2. Gaudino M, Cellini C, Pragliola C, Trani C,
Burzotta F, Schiavoni G, et al. Arterial versus ve-
nous bypass grafts in patients with in-stent resteno-
sis. Circulation. 2005;112(9 Suppl):I265-9.
3. Benedetto U, Angeloni E, Refice S, Sinatra R. Ra-
dial artery versus saphenous vein graft patency:
meta-analysis of randomized controlled trials.
J Thorac Cardiovasc Surg. 2010;139:229-31.
4. Gaudino M, Luciani N, Glieca F, Cellini C,
Pragliola C, Trani C, et al. Patients with in-stent reste-
nosis have an increased risk of mid-term venous graft
failure. Ann Thorac Surg. 2006;82:802-5.
5. GomesW, Buffolo E. Coronary stenting and inflam-
mation: implications for further surgical and medi-
cal treatment. Ann Thorac Surg. 2006;81:1918-25.
doi:10.1016/j.jtcvs.2010.01.041The JournalReply to the Editor:
We thank Nezic and colleagues for
their interest in our recent article.1 We
regret to point out, however, that
Nezic and colleagues misrepresent
data reported by Gaudino and associ-
ates.2 In fact, 2 different analyses
were reported in that study. First, Gau-
dino and associates2 reported an an-
giographic comparison of radial
artery (RA) and saphenous vein graft
(SVG) conduits randomly assigned
to target obtuse marginal coronary ar-
teries (OMs) with previous stenting
(study group) versus OMs without
previous (control group). The results
of this comparison were shown in
Gaudino and associates’ Table 3,2
which compared 20 RA conduits
versus 20 SVG conduits from the
study group and 20 RA conduits ver-
sus 20 SVG conduits from the control
group. In addition, they reported an-
giographic results of other conduits
not randomly assigned to complete re-
vascularization in both the study and
control groups (see Gaudino and asso-
ciates’ Table 22).
For the purpose of ourmeta-analysis
of randomized, controlled trials, we in-
cluded only conduits randomly as-
signed to target OMs. Therefore, in
our study the Gaudino I study included
RA versus SVG conduits randomly
grafted to previously stented OMs,
and the Gaudino II study included
RA versus SVG conduits grafted to un-
stented OMs. The risk that intrastent
restenosis would influence the results
was exactly the same for all RA and
SVG conduits used in the first cohort
of patients (Gaudino I). Nezic and
colleagues picked up data referring
to conduits not randomly assigned to
complete revascularization (see Gau-
dino and associates’ Table 2), thus
completely misrepresenting the inclu-
sion criteria adopted in our meta-
analysis of randomized, controlled
trials.
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To the Editor:
The meta-analytical review by
Benedetto and colleagues1 comparing
failure rates of radial artery (RA) and
saphenous vein (SV) conduits in coro-
nary artery bypass grafting has several
methodologic flaws that significantly
limit its validity. Consequently, we
strongly believe that both the data pre-
sented and the conclusion that ‘‘no
definitive evidence supports the superi-
ority of the RA over the SV in terms of
graft failure rate’’1 cannot be accepted
without challenge.
Benedetto and colleagues’ restrictive
inclusion criteria1 may have excluded
data from several high-quality studies
that considered different target lesions
or used definitions of graft failure other
than total graft occlusion or severe dif-
fuse graft narrowing (string sign).1 An-
giographic stenosis of more than 50%,
70%, or 75%, for example, may cause
symptomatic ischemia and may require
repeated angiography. Finally, Bene-
detto and colleagues1 appear to have ex-
cluded important studies in which
assessment of angiographic patency
was performed at a fixed interval as a
secondary end point. These restrictive
inclusion criteria compromise they c Volume 139, Number 6 1669
